David Miles
Impact in
Papers in
- Oncology 57
- Cancer Treatment and Pharmacology 46
- HER2/EGFR in Cancer Research 21
- Colorectal Cancer Treatments and Studies 16
-
- Housing Market and Economics 18
- Co-authors
- Herbert I. Hurwitz (2 shared papers)Alan B. Sandler (1 shared paper)Robert L. Coleman (1 shared paper)Olivier Chinot (1 shared paper)Regula Deurloo (1 shared paper)Josep Garcia (1 shared paper)Joyce O’Shaughnessy (5 shared papers)Vladimir Moiseyenko (4 shared papers)
- Journals
- The Economic Journal (12 papers)Journal of Clinical Oncology (11 papers)Cancer Research (10 papers)European Journal of Cancer (7 papers)International Journal of Clinical Practice (5 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
David Miles
136 papers receiving 5.4k citations
David Miles's Hit Papers
Peers
Comparison fields: 5 of 190
- Finance 1.1k
- Oncology 2.6k
- Cancer Research 1.1k
- General Economics, Econometrics and Finance 598
- Accounting 677
Countries citing papers authored by David Miles
This map shows the geographic impact of David Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Miles more than expected).
Fields of papers citing papers by David Miles
This network shows the impact of papers produced by David Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Miles. The network helps show where David Miles may publish in the future.
Co-authors
The 25 scholars most cited alongside David Miles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results Hit paper breakdown → | 2002 | 855 |
| 2 | Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook Hit paper breakdown → | 2020 | 780 |
| 3 | 2001 | 258 | |
| 4 | 2012 | 240 | |
| 5 | 2012 | 237 | |
| 6 | 2010 | 224 | |
| 7 | 1999 | 175 | |
| 8 | 2008 | 167 | |
| 9 | 1999 | 153 | |
| 10 | 1990 | 139 | |
| 11 | 2002 | 122 | |
| 12 | 2010 | 118 | |
| 13 | 2003 | 117 | |
| 14 | 2003 | 95 | |
| 15 | The UK Mortgage Market: Taking a Longer-Term View | 2004 | 86 |
| 16 | 1993 | 86 | |
| 17 | 2010 | 83 | |
| 18 | 2003 | 82 | |
| 19 | 1997 | 82 | |
| 20 | 1996 | 77 |
About David Miles
David Miles is a scholar working on Oncology, Economics and Econometrics, Accounting, Finance and Cancer Research, having authored 142 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (46 papers), Financial Literacy, Pension, Retirement Analysis (25 papers), Breast Cancer Treatment Studies (24 papers), HER2/EGFR in Cancer Research (21 papers), Advanced Breast Cancer Therapies (20 papers), Housing Market and Economics (18 papers), Colorectal Cancer Treatments and Studies (16 papers) and Global Health Care Issues (12 papers). The work is most often cited by research in Finance (1.1k citations), Oncology (2.6k citations), Cancer Research (1.1k citations), General Economics, Econometrics and Finance (598 citations) and Accounting (677 citations). David Miles has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Herbert I. Hurwitz, Alan B. Sandler, Robert L. Coleman, Olivier Chinot, Regula Deurloo, Josep Garcia, Joyce O’Shaughnessy, Vladimir Moiseyenko, L. Mauriac and Andrew Scott. Their work appears in journals such as The Economic Journal, Journal of Clinical Oncology, Cancer Research, European Journal of Cancer and International Journal of Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.